Chronic Myeloid Leukemia, Chronic Phase research hub

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

This study is testing a new medicine called TERN-701 for people with a type of blood cancer called Chronic Myeloid Leukemia (CML) that hasn't responded well to other treatments. It aims to check if the medicine is safe, what dose works best, and if it helps treat the cancer.